Internal Server Error

Immudex - About the company

Immudex is a series A company based in Copenhagen (Denmark), founded in 2009 by Liselotte Brix and Henrik Pedersen. It operates as a Provider of immune monitoring reagents and services for research and clinical use. Immudex has raised $16.4M in funding, with a current valuation of $*****. The company has 758 active competitors, including 48 funded and 93 that have exited. Its top competitors include companies like Abcam, Enzo and Meridian Bioscience.

Company Details

Provider of immune monitoring reagents and services for research and clinical use. It offers a portfolio of products, including dextramer reagents for flow cytometry and other applications, Klickmer reagents, and custom solutions. The products are used to detect and characterize antigen specific immune cells, supporting research in areas such as vaccine development, cell therapy, and infectious disease. It also provides services such as custom allele production and proficiency testing. Its offerings enable researchers and clinicians to gain a deeper understanding of the immune response in various contexts.It provides a range of products and services such as Dextramer and dcode MHC multimers for detailed immune profiling, clinical grade reagents, monomers and U- Load reagents, techincal and scientfic support, and more.
Social
X
Phone Number
+45 **********
Registered Address
Bredevej 2 A
Key Metrics
Founded Year
2009
Location
Copenhagen, Denmark
Stage
Series A
Total Funding
$16.4M in 12 rounds
Latest Funding Round
Ranked
Employee Count
46 as on Jun 30, 2026
Similar Companies
Sign up to download Immudex's company profile

Immudex's funding and investors

Immudex has raised a total funding of $16.4M over 12 rounds. Its first funding round was on Nov 04, 2009. Immudex has 2 angel investors.

Here is the list of recent funding rounds of Immudex:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Feb 10, 2025
4879639
Series A
3542017
4251440
5319206
7493337
Feb 01, 2024
6681854
Series A
2189561
1210876
8555348
1900215
Mar 20, 2023
4118703
Series A
4386527
1941776
1254635
8269723
lockAccess funding benchmarks and valuations. Sign up today!

Immudex's founders and board of directors

Founder? Claim Profile
The founders of Immudex are Liselotte Brix and Henrik Pedersen.
Here are the details of Immudex's key team members:

Immudex's Board of Directors

Immudex's board has 4 active members. Patrik Olof Dahlén, Søren Elmann Ingerslev, Helene Kahler Hjenner and Douglas Frank Sweet are independent board members.
Here is the list of Immudex's board of directors:
Name
Type
Representing
Status
Duration
Independent board member
-
Current
11y 7m
szbfxbr
Independent board member
-
Current
2y 8m
ysnluty
Independent board member
-
Current
6y 2m
ztytuac
Independent board member
-
Current
7y 2m

Immudex's employee count trend

Immudex has 46 employees as of Jun 26. Here is Immudex's employee count trend over the years:
Employee count trend for Immudex
lockUncover Immudex's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

Immudex's Competitors and alternates

Top competitors of Immudex include Abcam, Enzo and Meridian Bioscience. Here is the list of Top 10 competitors of Immudex, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Abcam
Abcam
1998, Cambridge (United Kingdom), Acquired
Developer of biological reagents for life science research
$78.8M
76/100
2nd
Logo for Enzo
Enzo
1976, Farmingdale (United States), Acquired
Life science products and services for research, drug discovery, and manufacturing
$7M
-
65/100
3rd
Logo for Meridian Bioscience
Meridian Bioscience
1976, Ohio (United States), Acquired
Molecular diagnostic device and kits
-
65/100
4th
Logo for Firefly BioWorks
Firefly BioWorks
2009, Cambridge (United States), Acquired
Develops platform to allow multiplexed assays on standard laboratory instrumentation
$3.77M
59/100
5th
Logo for Huwel Life
Huwel Life
2015, Hyderabad (India), Series A
Molecular diagnostic solutions and products for the healthcare industry
$5.74M
59/100
6th
Logo for BioLamina
BioLamina
2008, Sundbyberg (Sweden), Series B
Cell culture reagents for stem cell research
$18.2M
56/100
7th
Logo for Luminex
Luminex
1995, Austin (United States), Acquired
Developer of instruments, reagents and kits for clinical diagnostics and life science research
-
55/100
8th
Logo for Teknova
Teknova
1996, Hollister (United States), Public
Provider of molecular biology research reagents and kits
-
55/100
9th
Logo for PL BioScience
PL BioScience
2015, Aachen (Germany), Series A
Manufacturer of human platelet lysate products for cell culture applications
$13M
55/100
10th
Logo for Genetix Biotech
Genetix Biotech
2001, Delhi (India), Unfunded
Provider of kits and reagents for life sciences companies
-
-
54/100
54th
Logo for Immudex
Immudex
2009, Copenhagen (Denmark), Series A
Provider of immune monitoring reagents and services for research and clinical use
$16.4M
-
38/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on Immudex's competitors? Click here to see the top ones

Immudex's Investments and acquisitions

Immudex has made no investments or acquisitions yet.

Reports related to Immudex

Here is the latest report on Immudex's sector:

News related to Immudex

LinkedInImmudex
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about Immudex

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford